{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:54:09Z","timestamp":1780102449384,"version":"3.54.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG046139"],"award-info":[{"award-number":["U01 AG046139"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG046139"],"award-info":[{"award-number":["U01 AG046139"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State of Florida Ed & Ethel Moore Alzheimer\u2019s Disease Research Program","award":["8AZ16"],"award-info":[{"award-number":["8AZ16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The S209F variant of Abelson Interactor Protein 3 (\n                      <jats:italic>ABI3<\/jats:italic>\n                      ) increases risk for Alzheimer\u2019s disease (AD), but little is known about its function in relation to AD pathogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here, we use a mouse model that is deficient in\n                      <jats:italic>Abi3<\/jats:italic>\n                      locus to study how the loss of function of\n                      <jats:italic>Abi3<\/jats:italic>\n                      impacts two cardinal neuropathological hallmarks of AD\u2014amyloid \u03b2 plaques and tau pathology. Our study employs extensive neuropathological and transcriptomic characterization using transgenic mouse models and adeno-associated virus-mediated gene targeting strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Analysis of bulk RNAseq data confirmed age-progressive increase in Abi3 levels in rodent models of AD-type amyloidosis and upregulation in AD patients relative to healthy controls. Using RNAscope in situ hybridization, we localized the cellular distribution of Abi3 in mouse and human brains, finding that Abi3 is expressed in both microglial and non-microglial cells. Next, we evaluated\n                      <jats:italic>Abi3<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212<\/jats:italic>\n                        \/\u2212\n                      <\/jats:sup>\n                      mice and document that both\n                      <jats:italic>Abi3<\/jats:italic>\n                      and its overlapping gene,\n                      <jats:italic>Gngt2<\/jats:italic>\n                      , are disrupted in these mice. Using multiple transcriptomic datasets, we show that expression of\n                      <jats:italic>Abi3<\/jats:italic>\n                      and\n                      <jats:italic>Gngt2<\/jats:italic>\n                      are tightly correlated in rodent models of AD and human brains, suggesting a tight co-expression relationship. RNAseq of the\n                      <jats:italic>Abi3<\/jats:italic>\n                      -\n                      <jats:italic>Gngt<\/jats:italic>\n                      2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice revealed upregulation of\n                      <jats:italic>Trem2<\/jats:italic>\n                      ,\n                      <jats:italic>Plcg2<\/jats:italic>\n                      , and\n                      <jats:italic>Tyrobp<\/jats:italic>\n                      , concomitant with induction of an AD-associated neurodegenerative signature, even in the absence of AD-typical neuropathology. In\n                      <jats:italic>APP<\/jats:italic>\n                      mice, loss of\n                      <jats:italic>Abi3<\/jats:italic>\n                      -\n                      <jats:italic>Gngt2<\/jats:italic>\n                      resulted in a gene dose- and age-dependent reduction in A\u03b2 deposition. Additionally, in\n                      <jats:italic>Abi3<\/jats:italic>\n                      -\n                      <jats:italic>Gngt2<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice, expression of a pro-aggregant form of human tau exacerbated tauopathy and astrocytosis. Further, using in vitro culture assays, we show that the AD-associated S209F mutation alters the extent of ABI3 phosphorylation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These data provide an important experimental framework for understanding the role of\n                      <jats:italic>Abi3<\/jats:italic>\n                      -\n                      <jats:italic>Gngt2<\/jats:italic>\n                      function and early inflammatory gliosis in AD. Our studies also demonstrate that inflammatory gliosis could have opposing effects on amyloid and tau pathology, highlighting the unpredictability of targeting immune pathways in AD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-022-01044-1","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:27:53Z","timestamp":1659079673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Deletion of Abi3\/Gngt2 influences age-progressive amyloid \u03b2 and tau pathologies in distinctive ways"],"prefix":"10.1186","volume":"14","author":[{"given":"Kristen R.","family":"Ibanez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen N.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariet","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B.","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa Gonzalez","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Quicksall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-3776","authenticated-orcid":false,"given":"Paramita","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","DOI":"10.1016\/j.jalz.2018.03.004"},{"issue":"6","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.neuron.2019.02.027","volume":"101","author":"TE Golde","year":"2019","unstructured":"Golde TE. Harnessing immunoproteostasis to treat neurodegenerative disorders. Neuron. 2019;101(6):1003\u201315.","journal-title":"Neuron"},{"key":"1044_CR3","doi-asserted-by":"crossref","unstructured":"Kinney JW, et al. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","DOI":"10.1016\/j.trci.2018.06.014"},{"key":"1044_CR4","doi-asserted-by":"crossref","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","DOI":"10.1083\/jcb.201709069"},{"key":"1044_CR5","doi-asserted-by":"crossref","unstructured":"Efthymiou AG, Goate AM. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017;12(1):43.","DOI":"10.1186\/s13024-017-0184-x"},{"key":"1044_CR6","doi-asserted-by":"crossref","unstructured":"Sims R, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373.","DOI":"10.1038\/ng.3916"},{"issue":"1","key":"1044_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-018-0289-x","volume":"13","author":"OJ Conway","year":"2018","unstructured":"Conway OJ, et al. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. Mol Neurodegener. 2018;13(1):53.","journal-title":"Mol Neurodegener"},{"key":"1044_CR8","doi-asserted-by":"crossref","unstructured":"Wightman DP, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53(9):1276\u201382.","DOI":"10.1038\/s41588-021-00921-z"},{"key":"1044_CR9","doi-asserted-by":"crossref","unstructured":"Miyazaki K, et al. Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochim Biophys Acta. 2000;1493(1\u20132):237\u201341.","DOI":"10.1016\/S0167-4781(00)00158-5"},{"issue":"8","key":"1044_CR10","first-page":"2215","volume":"62","author":"Y Ichigotani","year":"2002","unstructured":"Ichigotani Y, et al. Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. Cancer Res. 2002;62(8):2215\u20139.","journal-title":"Cancer Res"},{"key":"1044_CR11","doi-asserted-by":"crossref","unstructured":"Satoh JI, et al. Microglia express ABI3 in the brains of Alzheimer\u2019s disease and Nasu-Hakola disease. Intractable Rare Dis Res. 2017;6(4):262\u20138.","DOI":"10.5582\/irdr.2017.01073"},{"issue":"12","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.cell.2021.04.021","volume":"184","author":"Z Yao","year":"2021","unstructured":"Yao Z, et al. A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell. 2021;184(12):3222-3241 e26.","journal-title":"Cell"},{"issue":"4","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"e34677","DOI":"10.1371\/journal.pone.0034677","volume":"7","author":"J Bae","year":"2012","unstructured":"Bae J, et al. NESH regulates dendritic spine morphology and synapse formation. PLoS ONE. 2012;7(4):e34677.","journal-title":"PLoS ONE"},{"key":"1044_CR14","doi-asserted-by":"crossref","unstructured":"Janus C, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease. Nature. 2000;408(6815):979\u201382.","DOI":"10.1038\/35050110"},{"issue":"6","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"e67680","DOI":"10.1371\/journal.pone.0067680","volume":"8","author":"P Chakrabarty","year":"2013","unstructured":"Chakrabarty P, et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS ONE. 2013;8(6):e67680.","journal-title":"PLoS ONE"},{"issue":"19","key":"1044_CR16","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1093\/hmg\/ddz151","volume":"28","author":"EJ Koller","year":"2019","unstructured":"Koller EJ, Gonzalez De La Cruz E, Machula T, Ibanez KR, Lin WL, Williams T, Riffe CJ, Ryu D, Strang KH, Liu X, Janus C, Golde TE, Dickson DW, Giasson BI, Chakrabarty P. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy. Hum Mol Genet. 2019;28(19):3255.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"8","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence M, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol. 2013;9(8):e1003118.","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"1044_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"36","key":"1044_CR20","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929\u201347.","journal-title":"J Neurosci"},{"key":"1044_CR21","doi-asserted-by":"crossref","unstructured":"Chen WT, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell. 2020;182(4):976-991 e19.","DOI":"10.1016\/j.cell.2020.06.038"},{"key":"1044_CR22","doi-asserted-by":"crossref","unstructured":"Friedman BA, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep. 2018;22(3):832\u201347.","DOI":"10.1016\/j.celrep.2017.12.066"},{"issue":"1","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(1):253-271 e6.","journal-title":"Immunity"},{"key":"1044_CR24","doi-asserted-by":"crossref","unstructured":"Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-1290 e17.","DOI":"10.1016\/j.cell.2017.05.018"},{"issue":"3","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566-581 e9.","journal-title":"Immunity"},{"key":"1044_CR26","doi-asserted-by":"crossref","unstructured":"Sala Frigerio C, et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to abeta plaques. Cell Rep. 2019;27(4):1293-1306 e6.","DOI":"10.1016\/j.celrep.2019.03.099"},{"key":"1044_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"1044_CR28","doi-asserted-by":"publisher","first-page":"i11","DOI":"10.18637\/jss.v046.i11","volume":"46","author":"P Langfelder","year":"2012","unstructured":"Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw. 2012;46(11):i11.","journal-title":"J Stat Softw"},{"issue":"2","key":"1044_CR29","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","volume":"11","author":"MD Young","year":"2010","unstructured":"Young MD, et al. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 2010;11(2):R14.","journal-title":"Genome Biol"},{"issue":"6","key":"1044_CR30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, et al. Changes in the synaptic proteome in tauopathy and rescue of Tau-induced synapse loss by C1q antibodies. Neuron. 2018;100(6):1322-1336 e7.","journal-title":"Neuron"},{"issue":"2","key":"1044_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","volume":"132","author":"M Allen","year":"2016","unstructured":"Allen M, et al. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol. 2016;132(2):197.","journal-title":"Acta Neuropathol"},{"key":"1044_CR32","doi-asserted-by":"crossref","unstructured":"De Jager PL, et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci Data. 2018;5:180142.","DOI":"10.1038\/sdata.2018.142"},{"key":"1044_CR33","doi-asserted-by":"crossref","unstructured":"Wan YW, et al. Meta-analysis of the Alzheimer\u2019s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 2020;32(2):107908.","DOI":"10.1016\/j.celrep.2020.107908"},{"issue":"10","key":"1044_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/genes10100759","volume":"10","author":"R Al-Ouran","year":"2019","unstructured":"Al-Ouran R, et al. A portal to visualize transcriptome profiles in mouse models of neurological disorders. Genes (Basel). 2019;10(10):759.","journal-title":"Genes (Basel)"},{"key":"1044_CR35","first-page":"194","volume":"7","author":"DG Walker","year":"2020","unstructured":"Walker DG. Defining activation states of microglia in human brain tissue: an unresolved issue for Alzheimer\u2019s disease. Neuroimmunol Neuroinflamm. 2020;7:194\u2013214.","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"1044_CR36","doi-asserted-by":"crossref","unstructured":"Liu CY, et al. Emerging roles of astrocytes in neuro-vascular unit and the tripartite synapse with emphasis on reactive gliosis in the context of Alzheimer\u2019s disease. Front Cell Neurosci. 2018;12:193.","DOI":"10.3389\/fncel.2018.00193"},{"issue":"4","key":"1044_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.semcdb.2013.01.007","volume":"24","author":"MC Mendoza","year":"2013","unstructured":"Mendoza MC. Phosphoregulation of the WAVE regulatory complex and signal integration. Semin Cell Dev Biol. 2013;24(4):272\u20139.","journal-title":"Semin Cell Dev Biol"},{"issue":"7638","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"1","key":"1044_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","volume":"12","author":"F Llorens","year":"2017","unstructured":"Llorens F, et al. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017;12(1):83.","journal-title":"Mol Neurodegener"},{"key":"1044_CR40","doi-asserted-by":"crossref","unstructured":"Zhou Y, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26(1):131\u201342.","DOI":"10.1038\/s41591-019-0695-9"},{"key":"1044_CR41","doi-asserted-by":"crossref","unstructured":"Zhang B, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153(3):707\u201320.","DOI":"10.1016\/j.cell.2013.03.030"},{"key":"1044_CR42","doi-asserted-by":"crossref","unstructured":"Patir A, et al. A core transcriptional signature of human microglia: derivation and utility in describing region-dependent alterations associated with Alzheimer\u2019s disease. Glia. 2019;67(7):1240\u201353.","DOI":"10.1002\/glia.23572"},{"key":"1044_CR43","doi-asserted-by":"crossref","unstructured":"Beckman D, et al. A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.\u00a0Alzheimers Dement. 2021;17(6):933\u201345.","DOI":"10.1002\/alz.12318"},{"key":"1044_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12964-015-0119-5","volume":"13","author":"S Sekino","year":"2015","unstructured":"Sekino S, et al. The NESH\/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex. Cell Commun Signal. 2015;13:41.","journal-title":"Cell Commun Signal"},{"issue":"44","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"32442","DOI":"10.1074\/jbc.M702583200","volume":"282","author":"CH Huang","year":"2007","unstructured":"Huang CH, et al. The involvement of Abl and PTP61F in the regulation of Abi protein localization and stability and lamella formation in Drosophila S2 cells. J Biol Chem. 2007;282(44):32442\u201352.","journal-title":"J Biol Chem"},{"key":"1044_CR46","doi-asserted-by":"crossref","unstructured":"Simonazzi E, et al. Abi3 regulates microglial ramification and dynamic tissue surveillance in vivo. bioRxiv.\u00a02021.\u00a0https:\/\/www.biorxiv.org\/content\/10.1101\/2021.03.19.436147v1","DOI":"10.1101\/2021.03.19.436147"},{"key":"1044_CR47","doi-asserted-by":"crossref","unstructured":"Karahan H, et al. Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer\u2019s disease in a mouse model of Abeta amyloidosis. Sci Adv. 2021;7(45):eabe3954.","DOI":"10.1126\/sciadv.abe3954"},{"issue":"1","key":"1044_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener. 2017;12(1):74.","journal-title":"Mol Neurodegener"},{"issue":"40","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.1811411115","volume":"115","author":"FA Sayed","year":"2018","unstructured":"Sayed FA, et al. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A. 2018;115(40):10172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"1044_CR50","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A. 2017;114(43):11524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1044_CR51","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by beta-amyloid pathology. Neuron. 2021;109(8):1283-1301 e6.","journal-title":"Neuron"},{"issue":"7810","key":"1044_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582(7810):89\u201394.","journal-title":"Nature"},{"issue":"7","key":"1044_CR53","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965\u201377.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1044_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/geno.1997.4814","volume":"44","author":"OC Ong","year":"1997","unstructured":"Ong OC, et al. Gene structure and chromosome localization of the G gamma c subunit of human cone G-protein (GNGT2). Genomics. 1997;44(1):101\u20139.","journal-title":"Genomics"},{"key":"1044_CR55","doi-asserted-by":"crossref","unstructured":"Audrain M, et al. Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry. 2019;24(9):1383\u201397.","DOI":"10.1038\/s41380-018-0258-3"},{"key":"1044_CR56","doi-asserted-by":"crossref","unstructured":"Haure-Mirande JV, et al. Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in cerebral Abeta amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Abeta burden. Mol Psychiatry. 2019;24(3):431\u201346.","DOI":"10.1038\/s41380-018-0255-6"},{"key":"1044_CR57","doi-asserted-by":"crossref","unstructured":"Meilandt WJ, et al. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 Ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J Neurosci. 2020;40(9):1956\u201374.","DOI":"10.1523\/JNEUROSCI.1871-19.2019"},{"issue":"2","key":"1044_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22(2):191\u2013204.","journal-title":"Nat Neurosci"},{"key":"1044_CR59","doi-asserted-by":"crossref","unstructured":"Jay TR, et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J Exp Med. 2015;212(3):287\u201395.","DOI":"10.1084\/jem.20142322"},{"issue":"9","key":"1044_CR60","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","volume":"184","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, et al. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol. 2010;184(9):5333\u201343.","journal-title":"J Immunol"},{"issue":"10","key":"1044_CR61","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1096\/fj.15-275834","volume":"29","author":"A Li","year":"2015","unstructured":"Li A, et al. IFN-gamma promotes tau phosphorylation without affecting mature tangles. FASEB J. 2015;29(10):4384\u201398.","journal-title":"FASEB J"},{"issue":"6","key":"1044_CR62","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1172\/JCI31450","volume":"117","author":"SS Shaftel","year":"2007","unstructured":"Shaftel SS, et al. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007;117(6):1595\u2013604.","journal-title":"J Clin Invest"},{"key":"1044_CR63","doi-asserted-by":"crossref","unstructured":"Ghosh S, et al. Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci. 2013;33(11):5053\u201364.","DOI":"10.1523\/JNEUROSCI.4361-12.2013"},{"issue":"5","key":"1044_CR64","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee H, et al. Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial rna release and neuronal innate immune activation. Neuron. 2020;107(5):891-908 e8.","journal-title":"Neuron"},{"issue":"1","key":"1044_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K, et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68(1):19\u201331.","journal-title":"Neuron"},{"key":"1044_CR66","doi-asserted-by":"crossref","unstructured":"Lee S, et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models. Am J Pathol. 2010;177(5):2549\u201362.","DOI":"10.2353\/ajpath.2010.100265"},{"key":"1044_CR67","doi-asserted-by":"crossref","unstructured":"Hamelin L, et al. Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain. 2016;139(Pt 4):1252\u201364.","DOI":"10.1093\/brain\/aww017"},{"key":"1044_CR68","doi-asserted-by":"crossref","unstructured":"Fan Z, et al. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain. 2017;140(3):792\u2013803.","DOI":"10.1093\/brain\/aww349"},{"key":"1044_CR69","doi-asserted-by":"crossref","unstructured":"Patel AG, et al. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer\u2019s disease pathology in aged squirrel monkeys. Brain. 2021;144(7):2146\u201365.","DOI":"10.1093\/brain\/awab129"},{"key":"1044_CR70","doi-asserted-by":"crossref","unstructured":"Boros BD, et al. Dendritic spines provide cognitive resilience against Alzheimer\u2019s disease. Ann Neurol. 2017;82(4):602\u201314.","DOI":"10.1002\/ana.25049"},{"issue":"2","key":"1044_CR71","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, et al. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 2010;24(2):548\u201359.","journal-title":"FASEB J"},{"issue":"2","key":"1044_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, et al. Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol. 2015;129(2):207\u201320.","journal-title":"Acta Neuropathol"},{"key":"1044_CR73","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1742-2094-9-250","volume":"9","author":"TA Siddiqui","year":"2012","unstructured":"Siddiqui TA, et al. Regulation of podosome formation, microglial migration and invasion by Ca(2+)-signaling molecules expressed in podosomes. J Neuroinflammation. 2012;9:250.","journal-title":"J Neuroinflammation"},{"key":"1044_CR74","doi-asserted-by":"crossref","unstructured":"Craig-Schapiro R, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):903\u201312.","DOI":"10.1016\/j.biopsych.2010.08.025"},{"key":"1044_CR75","doi-asserted-by":"crossref","unstructured":"Lananna BV, et al. Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis. Sci Transl Med. 2020;12(574):eaax3519.","DOI":"10.1126\/scitranslmed.aax3519"},{"key":"1044_CR76","doi-asserted-by":"crossref","unstructured":"Magno L, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019;11(1):16.","DOI":"10.1186\/s13195-019-0469-0"},{"issue":"3","key":"1044_CR77","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535\u201350.","journal-title":"Cell"},{"issue":"4","key":"1044_CR78","doi-asserted-by":"publisher","first-page":"e34514","DOI":"10.1371\/journal.pone.0034514","volume":"7","author":"J Bae","year":"2012","unstructured":"Bae J, et al. F-actin-dependent regulation of NESH dynamics in rat hippocampal neurons. PLoS ONE. 2012;7(4):e34514.","journal-title":"PLoS ONE"},{"key":"1044_CR79","doi-asserted-by":"crossref","unstructured":"Griciuc A, et al. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103(5):820-835 e7.","DOI":"10.1016\/j.neuron.2019.06.010"},{"issue":"3","key":"1044_CR80","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/mcne.2000.0865","volume":"16","author":"KD Courtney","year":"2000","unstructured":"Courtney KD, et al. Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol Cell Neurosci. 2000;16(3):244\u201357.","journal-title":"Mol Cell Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01044-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01044-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01044-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:50:12Z","timestamp":1659081012000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01044-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01044-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.08.467701","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were done according to institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}